Granahan Investment Management, LLC Frequency Therapeutics, Inc. Transaction History

Granahan Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.7 - $5.72 $66,888 - $225,059	-39,346 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $18,235 - $26,193	-3,684 Reduced 8.56%	39,346 $202,000
Q3 2021 Nov 15, 2021	SELL	$6.96 - $9.25 $587,765 - $781,153	-84,449 Reduced 66.25%	43,030 $304,000
Q2 2021 Aug 16, 2021	BUY	$8.05 - $11.61 $202,554 - $292,130	25,162 Added 24.59%	127,479 $1.27 Million
Q1 2021 May 17, 2021	SELL	$7.99 - $55.01 $157,538 - $1.08 Million	-19,717 Reduced 16.16%	102,317 $972,000
Q4 2020 Feb 12, 2021	BUY	$18.65 - $40.0 $79,504 - $170,520	4,263 Added 3.62%	122,034 $4.3 Million
Q3 2020 Nov 12, 2020	BUY	$17.76 - $24.96 $157,033 - $220,696	8,842 Added 8.12%	117,771 $2.26 Million
Q2 2020 Aug 14, 2020	SELL	$14.65 - $24.9 $33,211 - $56,448	-2,267 Reduced 2.04%	108,929 $2.53 Million
Q1 2020 May 12, 2020	SELL	$16.36 - $27.55 $945,771 - $1.59 Million	-57,810 Reduced 34.21%	111,196 $1.98 Million
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $2.14 Million - $3.17 Million	169,006 New	169,006 $2.96 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.